COVID Vaccines Getting Parallel Review: ACIP To Begin Process Before FDA Decisions

To enable distribution of COVID-19 vaccines within 24 hours of emergency use authorization, the Center for Disease Control and Prevention and its Advisory Committee on Immunization Practices (ACIP) will likely begin developing recommendations about using the vaccines while FDA is conducting its review of the EUAs, HHS Secretary Alex Azar said.

“I’m working directly with CDC Director Robert Redfield on how we could convene the ACIP hopefully concurrent with the FDA review,” Health and Human Services Department